U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle June 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arthur J. Gallagher & Co, Datadog and Oracle, on Thursday.
HIGHLIGHTS
* Applied Materials Inc. AMAT.O: Barclays raises target price to $590 from $500 |
* Arthur J. Gallagher & Co. AJG.N: Jefferies raises to buy from hold |
* Datadog Inc DDOG.O: TD Cowen raises target price to $260 from $235 |
* General Dynamics Corp GD.N: Jefferies raises to buy from hold |
* Oracle Corp ORCL.N: Scotiabank cuts target price to $241 from $290 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Academy Sports and Outdoors ASO.O: Barclays cuts target price to $50 from $55 |
* Academy Sports and Outdoors Inc ASO.O: Barclays cuts target price to $50 from $55 |
* Advanced Drainage Systems Inc WMS.N: Jefferies initiates coverage with buy rating |
* Advanced Drainage Systems Inc WMS.N: Jefferies initiates coverage with target $175 |
* Advanced Micro Devices AMD.O: BofA Global Research ups price objective to $560 from $500 |
* Agios Pharmaceuticals Inc AGIO.O: JP Morgan cuts target price to $31 from $36 |
* Alibaba Group BABA.N: zephirin Group cuts price objective to $92 from $112 |
* Applied Materials Inc. AMAT.O: Barclays raises target price to $590 from $500 |
* Arthur J. Gallagher & Co. AJG.N: Jefferies raises target price to $265 from $235 |
* Arthur J. Gallagher & Co. AJG.N: Jefferies raises to buy from hold |
* Axsome Therapeutics Inc AXSM.O: Jefferies raises target price to $380 from $275 |
* Black Hills Corp BKH.N: BofA Global Research raises price objective to $78 from $76 |
* Black Hills Corp BKH.N: BofA Global Research raises to buy from neutral rating |
* Camden Property Trust CPT.N: Truist Securities raises target price to $123 from $118 |
* Caseys General Stores Inc CASY.O: BMO raises target price to $950 from $700 |
* Caseys General Stores Inc CASY.O: Jefferies raises target price to $1040 from $1000 |
* Caseys General Stores Inc CASY.O: UBS raises target price to $945 from $805 |
* Caseys General Stores Inc CASY.O: Wells Fargo raises target price to $960 from $910 |
* Chewy CHWY.N: Deutsche Bank cuts target price to $32 from $45 |
* Chewy Inc CHWY.N: Barclays cuts target price to $36 from $40 |
* Chewy Inc CHWY.N: Jefferies cuts target price to $23 from $31 |
* Chewy Inc CHWY.N: JP Morgan cuts target price to $29 from $35 |
* Chewy Inc CHWY.N: Moffettnathanson cuts to neutral from buy; cuts PT to $22 from $50 |
* Chewy Inc CHWY.N: Morgan Stanley cuts target price to $42 from $43 |
* Chewy Inc CHWY.N: Piper Sandler cuts target price to $30 from $48 |
* Chewy Inc CHWY.N: RBC cuts target price to $34 from $47 |
* Chewy Inc CHWY.N: TD Cowen cuts target price to $34 from $42 |
* Chewy Inc CHWY.N: UBS cuts target price to $24 from $32 |
* Citrotech Inc CITR.A: Northland Capital initiates coverage with outperform rating |
* Citrotech Inc CITR.A: Northland Capital initiates coverage with target price $16 |
* Cloudflare NET.N: Truist Securities raises target price to $250 from $225 |
* Clover Health Investments Corp CLOV.O: UBS raises target price to $4.75 from $2.75 |
* Community Trust Bancorp Inc CTBI.O: Piper Sandler assumes coverage with neutral rating |
* Community Trust Bancorp Inc CTBI.O: Piper Sandler assumes coverage with target $76 |
* Corebridge Financial Inc CRBG.N: Deutsche Bank cuts target price to $37 from $39 |
* Corteva Inc CTVA.N: Barclays raises target price to $91 from $84 |
* Cullinan Therapeutics Inc CGEM.O: Clear Street raises target price to $46 from $33 |
* Damora Therapeutics Inc DMRA.O: H.C. Wainwright initiates coverage with buy rating |
* Damora Therapeutics Inc DMRA.O: H.C. Wainwright initiates coverage with target $45 |
* Datadog Inc (Pre-Reincorporation) DDOG.O: Benchmark raises target to $260 from $230 |
* Datadog Inc DDOG.O: TD Cowen raises target price to $260 from $235 |
* Energy Vault Holdings Inc NRGV.N: Citigroup initiates coverage with neutral rating |
* Energy Vault Holdings Inc NRGV.N: Citigroup initiates coverage with price target $5.25 |
* Envista Holdings Corp NVST.N: Barclays cuts target price to $32 from $34 |
* Equitable Holdings Inc EQH.N: UBS raises target price to $63 from $58 |
* Extreme Networks Inc EXTR.O: Rosenblatt Securities raises target price to $39 from $29 |
* First Solar Inc FSLR.O: UBS raises target price to $330 from $290 |
* FirstEnergy Corp FE.N: UBS raises target price to $51 from $50 |
* GE Vernova Inc GEV.N: Jefferies cuts target price to $1210 from $1350 |
* Generac Holdings Inc GNRC.N: UBS raises target price to $335 from $305 |
* General Dynamics Corp GD.N: Jefferies raises target price to $400 from $380 |
* General Dynamics Corp GD.N: Jefferies raises to buy from hold |
* Glaukos Corp GKOS.N: Citigroup raises target price to $162 from $140 |
* Hartford Insurance Group Inc HIG.N: Piper Sandler cuts target price to $148 from $154 |
* Henry Schein Inc HSIC.O: BTIG raises to buy from neutral |
* Hinge Health Inc HNGE.N: Barclays raises target price to $70 from $62 |
* Hinge Health Inc HNGE.N: Needham raises target price to $76 from $63 |
* Hinge Health Inc HNGE.N: RBC raises target price to $75 from $65 |
* Hinge Health Inc HNGE.N: Truist Securities raises target price to $85 from $79 |
* Humacyte, Inc. HUMA.O: H.C. Wainwright raises target price to $4 from $3 |
* Incyte INCY.O: Guggenheim raises target price to $136 from $130 |
* Insmed Inc INSM.O: Guggenheim cuts target price to $207 from $226 |
* Intel INTC.O: BofA Global Research raises price objective to $135.00 from $96.00 |
* Intel INTC.O: BofA Global Research raises to buy from underperform rating |
* Jfrog Ltd FROG.O: Barclays raises target price to $88 from $75 |
* Jjill Inc JILL.N: William Blair cuts to market perform rating |
* Kla Corporation KLAC.O: Barclays raises target price to $2250 from $1700 |
* Lam Research Corporation LRCX.O: Barclays raises target price to $335 from $275 |
* Madrigal Pharmaceuticals MDGL.O: BofA Global Research cuts price objective to $542 from $550 |
* Mirum Pharmaceuticals MIRM.O: Morgan Stanley raises target price to $150 from $140 |
* Monro Inc MNRO.O: Wells Fargo cuts target price to $16 from $20 |
* Navan Inc NAVN.O: BMO raises target price to $30 from $22 |
* Navan Inc NAVN.O: BTIG raises target price to $30 from $26 |
* Navan Inc NAVN.O: Citigroup raises target price to $28 from $21 |
* Navan Inc NAVN.O: Jefferies raises target price to $26 from $18 |
* Navan Inc NAVN.O: Mizuho raises target price to $30 from $25 |
* Navan Inc NAVN.O: Morgan Stanley raises target price to $33 from $25 |
* Navan Inc NAVN.O: Needham raises target price to $30 from $25 |
* Navan Inc NAVN.O: Rosenblatt Securities raises target price to $27 from $24 |
* Navan Inc NAVN.O: TD Cowen raises target price to $29 from $28 |
* Navan, Inc. NAVN.O: Oppenheimer raises target price to $30 from $28 |
* Oklo Inc OKLO.N: UBS cuts target price to $55 from $60 |
* Oracle Corp ORCL.N: BMO raises target price to $220 from $200 |
* Oracle Corp ORCL.N: D.A. Davidson raises target price to $225 from $200 |
* Oracle Corp ORCL.N: Piper Sandler raises target price to $225 from $210 |
* Oracle Corp ORCL.N: Scotiabank cuts target price to $241 from $290 |
* Oracle Corp ORCL.N: Wedbush cuts target price to $240 from $275 |
* Oscar Health Inc OSCR.N: Barclays raises target price to $35 from $30 |
* Procept Biorobotics Corp PRCT.O: Leerink Partners cuts target price to $29 from $31 |
* Procept Biorobotics Corp PRCT.O: Leerink Partners cuts to market perform from outperform |
* Robinhood Markets Inc HOOD.O: Needham raises target price to $97 from $85 |
* Sensei Biotherapeutics Inc SNSE.O: BTIG initiates coverage with buy rating; PT $55 |
* Shoals Technologies Group Inc SHLS.O: Wells Fargo raises target price to $10 from $9 |
* Six Flags Entertainment Corp FUN.N: UBS raises target price to $30 from $27 |
* Spacex SPCX.O: New Street Research initiates coverage with $165 target price |
* Spacex SPCX.O: Oppenheimer initiates coverage with outperform rating; target price $190 |
* Stitch Fix Inc SFIX.O: UBS raises target price to $4.5 from $4 |
* Structure Therapeutics Inc GPCR.O: H.C. Wainwright cuts target price to $70 from $100 |
* Sutro Biopharma Inc STRO.O: Truist Securities assumes coverage with buy rating; PT $50 |
* The J.M. Smucker Company SJM.N: Barclays raises target price to $125 from $103 |
* Toast Inc TOST.N: Piper Sandler assumes coverage with overweight rating; PT $32 |
* Tronox Holdings Plc TROX.N: Truist Securities raises to hold from sell |
* Unusual Machines Inc UMAC.A: Needham raises target price to $30 from $22 |
* Vir Biotechnology Inc VIR.O: Morgan Stanley raises target price to $27 from $23 |
* Voyager Technologies Inc VOYG.N: BTIG initiates coverage with buy rating; PT $55 |
* Western Digital Corp WDC.O: JP Morgan raises target price to $650 from $530 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Caseys General Stores
See all newsU.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle
Casey’s General Stores Q4 revenue beats estimates, on the back of strong inside sales
U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy